| Marium Siddiqi, | |
|
1651 W University Dr # 100, Mckinney, TX 75069-3445 | |
| (972) 525-9900 | |
| (469) 333-7988 |
| Full Name | Marium Siddiqi |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 10 Years |
| Location | 1651 W University Dr # 100, Mckinney, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457705196 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | S4688 (Texas) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vmd Primary Providers North Texas Pllc | 2769896190 | 47 |
News Archive
More than 90 percent of Americans age 65 and older now have prescription drug coverage, compared to more than 75 percent who were covered in 2004, according to a University of Michigan analysis. And poor seniors are as likely to have coverage as the rich.
News media registration opened today for the American Chemical Society's (ACS') 243rd National Meeting & Exposition, one of the largest scientific conferences of the New Year.
Center for Companies That Care has announced that University HealthSystem Consortium was named to its Honor Roll, a national list recognizing employers for outstanding workplace practices and active community involvement, for the eighth consecutive year.
By combining a magnetic nanoparticle, a fluorescent quantum dot, and an anticancer drug within a lipid-based nanoparticle, a multi-institutional research team headed by members of the National Cancer Institute's (NCI) Alliance for Nanotechnology in Cancer has created a single agent that can image and treat tumors. In addition, this new nanoparticle is able to avoid detection by the immune system, enabling the particle to remain in the body for extended periods of time.
Judith Villablanca, MD, of The Saban Research Institute of Children's Hospital Los Angeles, Susan Kreissman, MD, of Duke University Medical Center, and colleagues reported the results of a randomized, phase 3 clinical trial conducted by the Children's Oncology Group examining the effect of selectively removing (purging) tumor cells from blood stem cells before they are transplanted back into patients with high-risk neuroblastoma following high-dose chemotherapy.
› Verified 3 days ago
| Entity Name | Vmd Primary Providers North Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295338358 PECOS PAC ID: 2769896190 Enrollment ID: O20210127000103 |
News Archive
More than 90 percent of Americans age 65 and older now have prescription drug coverage, compared to more than 75 percent who were covered in 2004, according to a University of Michigan analysis. And poor seniors are as likely to have coverage as the rich.
News media registration opened today for the American Chemical Society's (ACS') 243rd National Meeting & Exposition, one of the largest scientific conferences of the New Year.
Center for Companies That Care has announced that University HealthSystem Consortium was named to its Honor Roll, a national list recognizing employers for outstanding workplace practices and active community involvement, for the eighth consecutive year.
By combining a magnetic nanoparticle, a fluorescent quantum dot, and an anticancer drug within a lipid-based nanoparticle, a multi-institutional research team headed by members of the National Cancer Institute's (NCI) Alliance for Nanotechnology in Cancer has created a single agent that can image and treat tumors. In addition, this new nanoparticle is able to avoid detection by the immune system, enabling the particle to remain in the body for extended periods of time.
Judith Villablanca, MD, of The Saban Research Institute of Children's Hospital Los Angeles, Susan Kreissman, MD, of Duke University Medical Center, and colleagues reported the results of a randomized, phase 3 clinical trial conducted by the Children's Oncology Group examining the effect of selectively removing (purging) tumor cells from blood stem cells before they are transplanted back into patients with high-risk neuroblastoma following high-dose chemotherapy.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marium Siddiqi, Po Box 360541, Pittsburgh, PA 15251-6541 Ph: (972) 525-9900 | Marium Siddiqi, 1651 W University Dr # 100, Mckinney, TX 75069-3445 Ph: (972) 525-9900 |
News Archive
More than 90 percent of Americans age 65 and older now have prescription drug coverage, compared to more than 75 percent who were covered in 2004, according to a University of Michigan analysis. And poor seniors are as likely to have coverage as the rich.
News media registration opened today for the American Chemical Society's (ACS') 243rd National Meeting & Exposition, one of the largest scientific conferences of the New Year.
Center for Companies That Care has announced that University HealthSystem Consortium was named to its Honor Roll, a national list recognizing employers for outstanding workplace practices and active community involvement, for the eighth consecutive year.
By combining a magnetic nanoparticle, a fluorescent quantum dot, and an anticancer drug within a lipid-based nanoparticle, a multi-institutional research team headed by members of the National Cancer Institute's (NCI) Alliance for Nanotechnology in Cancer has created a single agent that can image and treat tumors. In addition, this new nanoparticle is able to avoid detection by the immune system, enabling the particle to remain in the body for extended periods of time.
Judith Villablanca, MD, of The Saban Research Institute of Children's Hospital Los Angeles, Susan Kreissman, MD, of Duke University Medical Center, and colleagues reported the results of a randomized, phase 3 clinical trial conducted by the Children's Oncology Group examining the effect of selectively removing (purging) tumor cells from blood stem cells before they are transplanted back into patients with high-risk neuroblastoma following high-dose chemotherapy.
› Verified 3 days ago
George W Childress, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6171 Virginia Pkwy Ste 200, Mckinney, TX 75071 Phone: 972-548-5377 Fax: 972-548-5447 | |
Melony Ann Chilcoat, APRN, FNP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2740 Virginia Pkwy Ste 100, Mckinney, TX 75071 Phone: 214-414-2880 Fax: 214-279-9639 | |
Dr. Kedrica Massa Taylor, DNP, APRN, FNP-BC Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1703 Rockhill Rd Apt 1131, Mckinney, TX 75069 Phone: 918-408-0560 | |
Dr. John L Washburn Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5220 W University Dr Ste 100, Mckinney, TX 75071 Phone: 469-800-5100 Fax: 469-800-5110 | |
Tina M Gingrich, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 4510 Medical Center Dr, Mckinney, TX 75069 Phone: 214-295-8675 Fax: 866-207-2534 | |
Ambreen Ashfaque, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4201 Medical Center Dr, Suite 380, Mckinney, TX 75069 Phone: 972-529-6939 Fax: 972-529-6935 | |
Mr. Billy R Boring Jr., MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 1441 Redbud Blvd, Ste 111, Mckinney, TX 75069 Phone: 972-542-2683 Fax: 972-548-7657 |